Clinical Trial Update: A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection

View source ↗

Summary

A follow-up clinical trial update evaluating the long-term safety and efficacy of CS-101 injections in participants with Beta-thalassemia, with enrollment by in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• CS-101

Snippet

Sponsor: CorrectSequence Therapeutics Co., Ltd | Conditions: Beta-Thalassemia | Status: ENROLLING_BY_INVITATION